Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond the blood: expanding CAR T cell therapy to solid tumors
Uğur Uslu, Carl H. June
Nature Biotechnology (2024)
Closed Access | Times Cited: 17

Showing 17 citing articles:

Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Emile M. Youssef, Brandon Fletcher, Dannelle Palmer
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 3
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 2
Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
Daisy Bhatia, Riccardo Dolcetti, Roberta Mazzieri
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
PD1-TLR10 fusion protein enhances the antitumor efficacy of CAR-T cells in colon cancer
Yuzheng Peng, Zhiming Huang, Yafei Wu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114083-114083
Closed Access
Gene armoring: A way to enhance CAR-T cell function
Yuxin Chen, Lulu Han, Ying Cai, et al.
Pharmacological Research (2025), pp. 107622-107622
Open Access
Peto’s paradox: 2 problems 2 answers
Chika Edward Uzoigwe
Frontiers in Ecology and Evolution (2025) Vol. 13
Open Access
Logros iniciales y retos pendientes de la terapia con células CAR-T en el Sistema Nacional de Salud español
Fermín Sánchez‐Guijo, Silvia Jiménez
Farmacia Hospitalaria (2025)
Open Access
[Translated article] Initial achievements and remaining challenges of CAR-T cell therapy in the Spanish National Health System
Fermín Sánchez‐Guijo, Silvia Jiménez
Farmacia Hospitalaria (2025)
Open Access
Engineered T cells and macrophages: two arms to seize solid tumors
Luigi Russo, Ilaria De Martino, M Marchetti, et al.
Current Opinion in Biotechnology (2025) Vol. 93, pp. 103296-103296
Open Access
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Adoptive immune cell therapy for colorectal cancer
Chenxiao Liu, Nan Liu, Tongcun Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
Xia Teng, Shance Li, Chaoting Zhang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Characterization of Lysate from NK-92 cells and its potential use as immunotherapeutic modality
Himani Chinnapen, Laurent Boissel, Courtney J. Fleenor, et al.
Cellular Immunology (2025), pp. 104951-104951
Closed Access
Spotlight on cancer immunotherapies

Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 453-454
Closed Access
Developing cell-based therapies for pancreatic ductal adenocarcinoma
Rachel Elizabeth Ann Fincham, Joe Yeong, Hemant M. Kocher
Journal of Clinical Investigation (2025) Vol. 135, Iss. 8
Open Access
CD70-targeted cancer theranostics: Progress and challenges
Weijun Wei, Viktor Grünwald, Ken Herrmann
Med (2025), pp. 100671-100671
Closed Access
Targeted degradation of membrane proteins
Grace Hohman, Muhammad Shahid, Mohamed A. Eldeeb
Nature Structural & Molecular Biology (2024)
Closed Access
Page 1

Scroll to top